These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34437734)

  • 1. And so they wait: The other epidemic among United States youth during COVID-19.
    Lee LK; Stewart A; Mannix R
    Acad Emerg Med; 2021 Nov; 28(11):1347-1348. PubMed ID: 34437734
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: Seroprevalence of SARS-CoV-2 After the Largest Initial Epidemic Wave in the United States: Findings from New York City, May 13-July 21, 2020.
    Allan-Blitz LT; Klausner JD
    J Infect Dis; 2021 Aug; 224(3):556-557. PubMed ID: 33963752
    [No Abstract]   [Full Text] [Related]  

  • 3. Analyses of the Duration and Dynamics of the COVID-19 Epidemic in 11 Severely Affected Countries.
    Chen C; Shi Q; Dong XP
    Biomed Environ Sci; 2021 Sep; 34(9):739-742. PubMed ID: 34530965
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 epidemic in the US-A gateway to screen for tuberculosis, HIV, viral hepatitides, Chagas disease, and other neglected tropical diseases among Hispanics.
    Schultz J; Hyson P; Chastain DB; Gharamti AA; Franco-Paredes C; Henao-Martínez AF
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008953. PubMed ID: 33338043
    [No Abstract]   [Full Text] [Related]  

  • 5. Intersecting U.S. Epidemics: COVID-19 and Lack of Health Insurance.
    Woolhandler S; Himmelstein DU
    Ann Intern Med; 2020 Jul; 173(1):63-64. PubMed ID: 32259195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons on Surviving a Pandemic From 35 Years of AIDS Cinema.
    McCarty EB; Wahlert L
    AMA J Ethics; 2021 May; 23(5):E423-427. PubMed ID: 34038352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future scenarios for the SARS-CoV-2 epidemic in Switzerland: an age-structured model.
    Estill J; Venkova-Marchevska P; Roelens M; Orel E; Temerev A; Flahault A; Keiser O
    F1000Res; 2020; 9():646. PubMed ID: 34631035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicomponent Strategies to Prevent SARS-CoV-2 Transmission - Nine Overnight Youth Summer Camps, United States, June-August 2021.
    Van Naarden Braun K; Drexler M; Rozenfeld RA; Deener-Agus E; Greenstein R; Agus M; Joffe M; Kasowitz A; Levy P; Nerwen C
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(40):1420-1424. PubMed ID: 34618796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus.
    Van Vo G; Bagyinszky E; Park YS; Hulme J; An SSA
    Adv Exp Med Biol; 2021; 1321():3-19. PubMed ID: 33656709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The WHO mission report struggles to trace the origins of the SARS-CoV-2 epidemic.
    Decroly E; Claverie JM; Canard B
    Virologie (Montrouge); 2021 Jun; 25(3):42-46. PubMed ID: 34112630
    [No Abstract]   [Full Text] [Related]  

  • 12. [The WHO mission report struggles to trace the origins of the SARS-CoV-2 epidemic].
    Decroly E; Claverie JM; Canard B
    Virologie (Montrouge); 2021 Jun; 25(3):148-152. PubMed ID: 34018943
    [No Abstract]   [Full Text] [Related]  

  • 13. [Patterns of the SARS-CoV-2 epidemic spread in a megacity].
    Akimkin VG; Kuzin SN; Semenenko TA; Shipulina OY; Yatsyshina SB; Tivanova EV; Kalenskaya AV; Solovyova IV; Vershinina MA; Kvasova OA; Ploskireva AA; Mamoshina MV; Elkina MA; Klushkina VV; Andreeva EE; Ivanenko AV
    Vopr Virusol; 2020 Sep; 65(4):203-211. PubMed ID: 33533223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan.
    Yamamoto S; Tanaka A; Oshiro Y; Ishii M; Ishiwari H; Konishi M; Matsuda K; Ozeki M; Miyo K; Maeda K; Mizoue T; Sugiura W; Mitsuya H; Sugiyama H; Ohmagari N
    J Infect; 2021 Aug; 83(2):237-279. PubMed ID: 34044036
    [No Abstract]   [Full Text] [Related]  

  • 15. When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis.
    Becker WC; Fiellin DA
    Ann Intern Med; 2020 Jul; 173(1):59-60. PubMed ID: 32240291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic variation in outcome of people hospitalised during the first COVID-19 epidemic wave in Wales (UK): an analysis of national surveillance data using Onomap, a name-based ethnicity classification tool.
    Thomas DR; Orife O; Plimmer A; Williams C; Karani G; Evans MR; Longley P; Janiec J; Saltus R; Shankar AG
    BMJ Open; 2021 Aug; 11(8):e048335. PubMed ID: 34408047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fitting and predicting trend of COVID-19 by SVEPIUHDR dynamic model].
    Chen JL; Jin ML; Wang X; Yang XJ; Zhang N; Liu FN; Liu R; Guo JP; Chen Y; Wang CJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Aug; 42(8):1341-1346. PubMed ID: 34814551
    [No Abstract]   [Full Text] [Related]  

  • 18. Low uptake of nurses in a mass screening programme for SARS-CoV-2 and its implications on epidemic control.
    Lee SS; Chan CP; Wong NS
    Infect Dis (Lond); 2021 Jun; 53(6):469-472. PubMed ID: 33612054
    [No Abstract]   [Full Text] [Related]  

  • 19. Intense SARS-CoV-2 transmission among affluent Manaus residents preceded the second wave of the epidemic in Brazil.
    Buss LF; Sabino EC
    Lancet Glob Health; 2021 Nov; 9(11):e1475-e1476. PubMed ID: 34678180
    [No Abstract]   [Full Text] [Related]  

  • 20. Conceptual lessons for containing an epidemic of questionable COVID-19 counterfactual comparisons.
    Fuller J
    J Epidemiol Community Health; 2021 Nov; 75(11):1031-1032. PubMed ID: 34407994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.